GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $87,000 | 0.0% | 2,000 | 0.0% | 0.01% | +28.6% |
| Q1 2022 | $87,000 | -1.1% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $88,000 | +6.0% | 2,000 | -7.5% | 0.01% | -12.5% |
| Q3 2021 | $83,000 | -3.5% | 2,161 | 0.0% | 0.01% | -11.1% |
| Q2 2021 | $86,000 | +2.4% | 2,161 | -8.5% | 0.01% | -10.0% |
| Q1 2021 | $84,000 | +740.0% | 2,361 | +804.6% | 0.01% | +900.0% |
| Q4 2020 | $10,000 | -75.6% | 261 | -76.1% | 0.00% | -85.7% |
| Q3 2020 | $41,000 | -6.8% | 1,091 | +1.5% | 0.01% | -12.5% |
| Q2 2020 | $44,000 | +29.4% | 1,075 | +20.7% | 0.01% | 0.0% |
| Q1 2020 | $34,000 | -17.1% | 891 | 0.0% | 0.01% | +14.3% |
| Q4 2019 | $41,000 | +7.9% | 891 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $38,000 | -77.4% | 891 | -78.8% | 0.01% | -78.1% |
| Q2 2019 | $168,000 | -4.0% | 4,193 | 0.0% | 0.03% | -11.1% |
| Q1 2019 | $175,000 | +9.4% | 4,193 | 0.0% | 0.04% | 0.0% |
| Q4 2018 | $160,000 | -5.3% | 4,193 | 0.0% | 0.04% | +5.9% |
| Q3 2018 | $169,000 | 0.0% | 4,193 | 0.0% | 0.03% | -2.9% |
| Q2 2018 | $169,000 | +0.6% | 4,193 | 0.0% | 0.04% | -12.5% |
| Q1 2018 | $168,000 | -13.0% | 4,193 | -23.9% | 0.04% | -11.1% |
| Q4 2017 | $193,000 | -13.1% | 5,509 | 0.0% | 0.04% | -21.1% |
| Q3 2017 | $222,000 | -6.3% | 5,509 | 0.0% | 0.06% | -12.3% |
| Q2 2017 | $237,000 | +2.2% | 5,509 | 0.0% | 0.06% | -3.0% |
| Q1 2017 | $232,000 | +11.5% | 5,509 | 0.0% | 0.07% | -1.5% |
| Q4 2016 | $208,000 | -14.8% | 5,509 | -2.8% | 0.07% | -20.0% |
| Q3 2016 | $244,000 | -11.9% | 5,670 | -13.3% | 0.08% | -18.3% |
| Q2 2016 | $277,000 | +7.8% | 6,543 | +3.4% | 0.10% | +1.0% |
| Q1 2016 | $257,000 | +238.2% | 6,325 | +237.7% | 0.10% | +221.9% |
| Q4 2015 | $76,000 | +11.8% | 1,873 | +5.6% | 0.03% | -11.1% |
| Q3 2015 | $68,000 | -11.7% | 1,773 | 0.0% | 0.04% | 0.0% |
| Q2 2015 | $77,000 | -6.1% | 1,773 | 0.0% | 0.04% | -5.3% |
| Q1 2015 | $82,000 | +6.5% | 1,773 | -1.9% | 0.04% | -5.0% |
| Q4 2014 | $77,000 | -13.5% | 1,808 | 0.0% | 0.04% | -23.1% |
| Q3 2014 | $89,000 | -8.2% | 1,808 | 0.0% | 0.05% | -11.9% |
| Q2 2014 | $97,000 | +38.6% | 1,808 | +38.2% | 0.06% | +28.3% |
| Q1 2014 | $70,000 | +100.0% | 1,308 | +96.7% | 0.05% | +84.0% |
| Q4 2013 | $35,000 | – | 665 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |